Latest Health News from Duke Medicine News and Communications
Surgical Complications of DBS No Higher Risk for Older Parkinson’s Patients
Aug. 25, 2014
Implantating deep brain stimulation devices poses no greater risk of complications to older patients than it does to younger patients with Parkinson’s disease, researchers at Duke Medicine report.
Gut Flora Influences HIV Immune Response
Aug. 13, 2014
Normal microorganisms in the intestines appear to play a pivotal role in how the HIV virus foils a successful attack from the body’s immune system, according to new research from Duke Medicine.
Molecule Enhances Copper’s Lethal Punch Against Microbes
July 31, 2014
Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.
Mechanism Found for Development of Protective HIV Antibodies
July 24, 2014
Scientists at Duke Medicine have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected.
Study Compares Cost-Effectiveness of Weight-Loss Programs and Drugs
July 22, 2014
In a cost-effectiveness analysis of commercial diet programs and pills, the Weight Watchers program and the drug Qsymia showed the best value for the money. The Jenny Craig regimen generated the greatest weight loss, but was also the most expensive option tested, according to researchers at Duke-National University of Singapore (NUS) Graduate Medical School.
Omega 3 Fatty Acids Lessen Severity of Osteoarthritis in Mice
July 11, 2014
Mice consuming a supplement of omega 3 fatty acids had healthier joints than those fed diets high in saturated fats and omega 6 fatty acids, according to Duke Medicine researchers.
New Technologies Fuel Patient Participation and Data Collection in Research
July 8, 2014
The changing dynamic of health studies driven by “big data” research projects will empower patients to become active participants who provide real-time information such as symptoms, side effects and clinical outcomes, according to researchers at Duke Medicine.
Duke Named to National Network Studying Rare Diseases
July 1, 2014
Duke University is one of six new clinical sites in the country that will participate in a recenty formed Undiagnosed Diseases Network established by the National Institutes of Health.
Duke, WakeMed Agree to Guidelines to Explore Clinical Collaborations
June 30, 2014
Duke Medicine and WakeMed Health & Hospitals have established a framework designed to guide exploratory discussions regarding clinical collaborations that could potentially enable the two organizations to work toward shared goals while maintaining their independence.
DCRI and Industry Collaboration Promotes Open Data Access
June 24, 2014
Duke University, through its Duke Clinical Research Institute (DCRI), announced this week it has entered into a novel collaboration with Bristol-Myers Squibb (BMS) to promote open access to clinical information from company-sponsored studies.